John Militello
Equibles does not estimate personal net worth.
Get an email with a short summary when Rocket Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get RCKT alertsAbout John Militello
John Militello is recorded as CFO at Rocket Pharmaceuticals, Inc. (RCKT) since March 16, 2022. Rocket Pharmaceuticals, Inc. reported in an 8-K filed June 30, 2026 that John Militello resigned as VP of Finance, Senior Controller, Treasurer and Principal Accounting Officer, effective July 7, 2026. The proxy statement of Rocket Pharmaceuticals, Inc. reports total compensation of $1,175,588 for John Militello in fiscal 2024, including a base salary of $341,455. Disclosed compensation is on record for 3 fiscal years. Rocket Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rocket Pharmaceuticals, Inc. includes Gaurav Shah (CEO and Board Member), Aaron Ondrey (CFO), Carlos Garcia-Parada (CFO) and 7 others.
“On June 24, 2026, John Militello informed Rocket Pharmaceuticals, Inc. (the "Company" or "Rocket") of his resignation as VP of Finance, Senior Controller, Treasurer and Principal Accounting Officer, effective July 7, 2026, to pursue other opportunities.”
Affiliation history
-
Current
2022-03-16–present
-
Rocket Pharmaceuticals, Inc. (RCKT)
Proxy statement
CurrentStart not stated–present
Last confirmed April 6, 2026
Company network
Leadership on record at Rocket Pharmaceuticals, Inc.
- Gaurav Shah CEO, Board Member
- Aaron Ondrey CFO
- Carlos Garcia-Parada CFO
- Chris Stevens COO
- Christopher Stevens COO
- Martin Wilson General Counsel
- Joseph Manhede Chief Accounting Officer
- Carsten Boess Board Member
- David P. Southwell Board Member
- Dr. Mikael Dolsten, M.D., Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Rocket Pharmaceuticals, Inc. (RCKT) | Principal Accounting Officer and Former Interim Principal Financial Officer, Vice President | $341,455 | $1,175,588 |
| 2023 | Rocket Pharmaceuticals, Inc. (RCKT) | Principal Accounting Officer and Former Interim Principal Financial Officer, Vice President | $409,014 | $1,527,570 |
| 2022 | Rocket Pharmaceuticals, Inc. (RCKT) | Principal Accounting Officer and Interim Principal Financial Officer, Vice President | $376,788 | $1,751,386 |